Antibacterial burst-release from minimal Ag-containing plasma polymer coatings.
Biomaterials releasing silver (Ag) are of interest because of their ability to inhibit pathogenic bacteria including antibiotic-resistant strains. In order to investigate the potential of nanometre-thick Ag polymer (Ag/amino-hydrocarbon) nanocomposite plasma coatings, we studied a comprehensive range of factors such as the plasma deposition process and Ag cation release as well as the antibacterial and cytocompatible properties. The nanocomposite coatings released most bound Ag within the first day of immersion in water yielding an antibacterial burst. The release kinetics correlated with the inhibitory effects on the pathogens Pseudomonas aeruginosa or Staphylococcus aureus and on animal cells that were in contact with these coatings. We identified a unique range of Ag content that provided an effective antibacterial peak release, followed by cytocompatible conditions soon thereafter. The control of the in situ growth conditions for Ag nanoparticles in the polymer matrix offers the possibility to produce customized coatings that initially release sufficient quantities of Ag ions to produce a strong adjacent antibacterial effect, and at the same time exhibit a rapidly decaying Ag content to provide surface cytocompatibility within hours/days. This approach seems to be favourable with respect to implant surfaces and possible Ag-resistance/tolerance built-up.
Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, CH-9014 St.Gallen, Switzerland.
Stefanie
S
Lischer
Enrico
E
Körner
Dawn J
DJ
Balazs
Dakang
D
Shen
Peter
P
Wick
Kathrin
K
Grieder
Dieter
D
Haas
Manfred
M
Heuberger
Dirk
D
Hegemann
D016475:3T3 Cells; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D020099:Coated Materials, Biocompatible / Q000494:pharmacology*; D005562:Formazans / Q000737:chemistry; D053768:Metal Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure; D051379:Mice; D008826:Microbial Sensitivity Tests; D046529:Microscopy, Electron, Transmission; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012834:Silver / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects*; D013778:Tetrazolium Salts / Q000737:chemistry; D056928:X-Ray Absorption Spectroscopy
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible; D005562:Formazans; D013778:Tetrazolium Salts; C079782:MTT formazan; D012834:Silver
Appl Environ Microbiol. 2007 Mar;73(6):1712-20
17261510
Prog Med Chem. 1994;31:351-70
8029478
Am J Infect Control. 1998 Dec;26(6):572-7
9836841
Toxicol Lett. 2008 Jun 30;179(2):93-100
18508209
J Mater Sci Mater Med. 2008 Apr;19(4):1523-7
17990080
J Antimicrob Chemother. 2007 Apr;59(4):587-90
17307768
Int J Med Sci. 2009 Sep 04;6(5):287-95
19834595
Int J Med Sci. 2009 Sep 01;6(5):227-33
19841729
Ann Occup Hyg. 2005 Oct;49(7):575-85
15964881
Small. 2008 Jun;4(6):746-50
18528852
Toxicol Lett. 2008 Jan 4;176(1):1-12
18022772
J Biomed Mater Res. 2002 Apr;60(1):206-15
11835177
Biomaterials. 2007 Oct;28(30):4521-34
17628662
J Biol Inorg Chem. 2007 May;12(4):527-34
17353996
ACS Nano. 2009 Feb 24;3(2):279-90
19236062
Biomaterials. 2006 Apr;27(10):2258-64
16313952
Anal Biochem. 1989 Jun;179(2):401-3
2774188
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Chem Soc Rev. 2006 Sep;35(9):780-9
16936926
Am J Respir Crit Care Med. 2005 Jun 1;171(11):1209-23
15695491
Orthopade. 2004 Apr;33(4):431-8
15146838
Anal Chem. 1995 Sep 1;67(17):2883-91
8779415